Connect with us

Business

Emyria (ASX:EMD) share price falling on news of MDMA therapy trial

Published

on

Shares in Emyria Ltd (ASX: EMD) are falling today after the company shared news of a psychedelic therapy program targeting post traumatic stress disorder (PTSD). At its intraday low, the Emyria share price has fallen by 5%.

At the time of writing, it has slightly recovered. Currently, the…



Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

The Perenti (ASX:PRN) share price is collapsing 29%. Here’s why
Codan (ASX:CDA) share price wobbles on news of a completed acquisition